Oral sea buckthorn oil attenuates tear film osmolarity and symptoms in individuals with dry eye

Journal of Nutrition

Volumn 140, Issue 8, 2010, Pages 1462-1468

  Larmo, Petra S ^a   Järvinen, Riikka L ^a   Setälä, Niko L ^a   Yang, Baoru ^a   Viitanen, Matti H ^b   Engblom, Janne R K ^c   Tahvonen, Raija L ^d   Kallio, Heikki P ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU CITY HOSPITAL   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d FINNISH FOREST RESEARCH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PLANT EXTRACT; SEA BUCKTHORN OIL; UNCLASSIFIED DRUG; ANTIOXIDANT; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; VEGETABLE OIL;

ADULT; AGED; ARTICLE; ATTENUATION; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRY EYE; EYE BURNING; FEMALE; FOLLOW UP; HIPPOPHAE RHAMNOIDES; HUMAN; HYPEROSMOLARITY; MAJOR CLINICAL STUDY; OSMOLARITY; RANDOMIZED CONTROLLED TRIAL; TEAR FILM; WINTER; CHEMISTRY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; LACRIMAL FLUID; MALE; MIDDLE AGED; PLANT SEED;

RHAMNACEAE;

ADULT; ANTIOXIDANTS; DOUBLE-BLIND METHOD; DRY EYE SYNDROMES; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; HIPPOPHAE; HUMANS; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; PLACEBOS; PLANT OILS; SEEDS; TEARS;

EID: 77955302243     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.109.118901     Document Type: Article

References (49)

1. Pflugfelder SC. Prevalence, burden, and pharmacoeconomics of dry eye disease. Am J Manag Care. 2008;14:S102-6.
2. The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5:93-107.
3. The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international dry eye WorkShop (2007). Ocul Surf. 2007;5:75-92.
4. Luo L, Li DQ, Corrales RM, Pflugfelder SC. Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface. Eye Contact Lens. 2005;31:186-93.
5. Lemp MA. Management of dry eye disease. Am J Manag Care. 2008;14:S88-101.
6. Miljanovic B, Trivedi KA, Dana MR, Gilbard JP, Buring JE, Schaumberg DA. Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am J Clin Nutr. 2005;82:887-93.
7. Kokke KH, Morris JA, Lawrenson JG. Oral omega-6 essential fatty acid treatment in contact lens associated dry eye. Cont Lens Anterior Eye. 2008;31:141-6.
8. Aragona P, Bucolo C, Spinella R, Giuffrida S, Ferreri G. Systemic omega-6 essential fatty acid treatment and PGE1 tear content in Sjögren's syndrome patients. Invest Ophthalmol Vis Sci. 2005;46:4474-9.
9. Macri A, Giuffrida S, Amico V, Iester M, Traverso CE. Effect of linoleic acid and γ-linolenic acid on tear production, tear clearance and on the ocular surface after photorefractive keratectomy. Graefes Arch Clin Exp Ophthalmol. 2003;241:561-6.
10. Barabino S, Rolando M, Camicione P, Ravera G, Zanardi S, Giuffrida S, Calabria G. Systemic linoleic and γ-linolenic acid therapy in dry eye syndrome with an inflammatory component. Cornea. 2003;22:97-101.
11. Blades KJ, Patel S, Aidoo KE. Oral antioxidant therapy for marginal dry eye. Eur J Clin Nutr. 2001;55:589-97.
12. Pharmacopeia of the People's Republic of China. English ed, 1st vol. Beijing: Chemical Industry Press; 2000.
13. Upadhyay NK, Kumar R, Mandotra SK, Meena RN, Siddiqui MS, Sawhney RC, Gupta A. Safety and healing efficacy of sea buckthorn (Hippophaë rhamnoides L.) seed oil on burn wounds in rats. Food Chem Toxicol. 2009;47:1146-53.
14. St George SD, Cenkowski S. Influence of harvest time on the quality of oil-based compounds in sea buckthorn (Hippophae rhamnoides L. ssp. sinensis) seed and fruit. J Agric Food Chem. 2007;55:8054-61.
15. Yang B, Erkkola R. Sea buckthorn oils, mucous membranes and Sjögren's syndrome with special reference to latest studies. In: Singh V, editor. Seabuckthorn (Hippophae L.): a multipurpose wonder plant. 3rd vol. Delhi: Daya Publishing House; 2008. p. 254-67.
16. Yang B, Kalimo KO, Mattila LM, Kallio SE, Katajisto JK, Peltota OJ, Kallio HP. Effects of dietary supplementation with sea buckthorn (Hippophae rhamnoides) seed and pulp oils on atopic dermatitis. J Nutr Biochem. 1999;10:622-30.
17. Basu M, Prasad R, Jayamurthy P, Pal K, Arumughan C, Sawhney RC. Anti-atherogenic effects of seabuckthorn (Hippophaea rhamnoides) seed oil. Phytomedicine. 2007;14:770-7.
18. Johansson AK, Korte H, Yang BR, Stanley JC, Kallio HP. Sea buckthorn berry oil inhibits platelet aggregation. J Nutr Biochem. 2000;11:491-5.
19. Luoto R, Kaprio J, Uutela A. Age at natural menopause and sociodemographic status in Finland. Am J Epidemiol. 1994;139:64-76.
20. Marten B, Pfeuffer M, Schrezenmeir J. Medium-chain triglycerides. Int Dairy J. 2006;16:1374-82.
21. Ågren JJ, Julkunen A, Penttilä I. Rapid separation of serum lipids for fatty acid analysis by a single aminopropyl column. J Lipid Res. 1992;33:1871-6.
22. Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5:108-23.
23. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the ocular surface disease index. Arch Ophthalmol. 2000;118:615-21.
24. Ozcura F, Aydin S, Helvaci MR. Ocular surface disease index for the diagnosis of dry eye syndrome. Ocul Immunol Inflamm. 2007;15:389-93.
25. Nichols KK. Patient-reported symptoms in dry dye disease. Ocul Surf. 2006;4:137-45.
26. Tomlinson A, Khanal S, Ramaesh K, Diaper C, McFadyen A. Tear film osmolarity: determination of a referent for dry eye diagnosis. Invest Ophthalmol Vis Sci. 2006;47:4309-15.
27. Lucca JA, Nunez JN, Farris RL. A comparison of diagnostic tests for keratoconjunctivitis sicca: Lactoplate, Schirmer, and tear osmolarity. CLAO J. 1990;16:109-12.
28. Lemp MA, Hamill JR Jr. Factors affecting tear film breakup in normal eyes. Arch Ophthalmol. 1973;89:103-5.
29. Pinna A, Piccinini P, Carta F. Effect of oral linoleic and γ-linolenic acid on meibomian gland dysfunction. Cornea. 2007;26:260-4.
30. Theander E, Horrobin DF, Jacobsson LT, Manthorpe R. Gammalinolenic acid treatment of fatigue associated with primary Sjögren's syndrome. Scand J Rheumatol. 2002;31:72-9.
31. Pholpramool C. Secretory effect of prostaglandins on the rabbit lacrimal gland in vivo. Prostaglandins Med. 1979;3:185-92.
32. Butovich IA. On the lipid composition of human meibum and tears: comparative analysis of nonpolar lipids. Invest Ophthalmol Vis Sci. 2008;49:3779-89.
33. Viau S, Maire MA, Pasquis B, Gregoire S, Acar N, Bron AM, Bretillon L, Creuzot-Garcher CP, Joffre C. Efficacy of a 2-month dietary supplementation with polyunsaturated fatty acids in dry eye induced by scopolamine in a rat model. Graefes Arch Clin Exp Ophthalmol. 2009;247:1039-50.
34. Schmitz G, Ecker J. The opposing effects of n-3 and n-6 fatty acids. Prog Lipid Res. 2008;47:147-55.
35. Calder PC. Polyunsaturated fatty acids and inflammatory processes: new twists in an old tale. Biochimie. 2009;91:791-5.
36. Paturi M, Tapanainen H, Reinivuo H, Pietinen P. Finravinto 2007. The National FINDIET 2007 Survey. Publications of the National Public Health Institute, Department of Health Promotion and Chronic Disease Prevention, Nutrition Unit. Helsinki, Finland [cited 2009 15 Sep]. Available from: http://www.ktl.fi/portal/suomi/osastot/eteo/yksikot/ravitsemusyksikko/ finravinto--tutkimus/.
37. Shine WE, McCulley JP. Association of meibum oleic acid with meibomian seborrhea. Cornea. 2000;19:72-4.
38. Jiang Q, Elson-Schwab I, Courtemanche C, Ames BN. γ-Tocopherol and its major metabolite, in contrast to a-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc Natl Acad Sci USA. 2000;97:11494-9.
39. Raffo A, Paoletti F, Antonelli M. Changes in sugar, organic acid, flavonol and carotenoid composition during ripening of berries of three seabuckthorn (Hippophae rhamnoides L.) cultivars. Eur Food Res Technol. 2004;219:360-8.
40. Salminen A, Lehtonen M, Suuronen T, Kaarniranta K, Huuskonen J. Terpenoids: natural inhibitors of NF-κB signaling with anti-inflammatory and anticancer potential. Cell Mol Life Sci. 2008;65:2979-99.
41. Yang BR, Kallio H. Composition and physiological effects of sea buckthorn (Hippophaë) lipids. Trends Food Sci Technol. 2002;13:160-7.
42. Peponis V, Papathanasiou M, Kapranou A, Magkou C, Tyligada A, Melidonis A, Drosos T, Sitaras NM. Protective role of oral antioxidant supplementation in ocular surface of diabetic patients. Br J Ophthalmol. 2002;86:1369-73.
43. Uchiyama E, Aronowicz JD, Butovich IA, McCulley JP. Increased evaporative rates in laboratory testing conditions simulating airplane cabin relative humidity: an important factor for dry eye syndrome. Eye Contact Lens. 2007;33:174-6.
44. Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol. 2000;118:1264-8.
45. Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea. 2004;23:762-70.
46. Liu H, Begley C, Chen M, Bradley A, Bonanno J, McNamara NA, Nelson JD, Simpson T. A link between tear instability and hyperosmolarity in dry eye. Invest Ophthalmol Vis Sci. 2009;50:3671-9.
47. Desbiens NA. In randomized controlled trials, should subjects in both placebo and drug groups be expected to guess that they are taking drug 50% of the time? Med Hypotheses. 2002;59:227-32.
48. McMonnies CW. Key questions in a dry eye history. J Am Optom Assoc. 1986;57:512-7.
49. Nichols KK, Nichols JJ, Mitchell GL. The reliability and validity of McMonnies dry eye index. Cornea. 2004;23:365-71.